Archives: “Archives”

Showing 11 - 20 of 41 posts

Christoph Ellebrecht, MD

https://www.coltonconsortium.org/directory/christoph-ellebrecht-md/

Assistant Professor, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania Dr. Christoph Ellebrecht is an Assistant Professor of Dermatology at the Perelman School of Medicine, University of Pennsylvania, […]

Jill P. Buyon, MD

https://www.coltonconsortium.org/directory/jill-p-buyon-md/

Sir Deryck and Lady Va Maughan Professor of Rheumatology, Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health Director, Division of Rheumatology, NYU Grossman School of Medicine […]

Christopher Pittenger, MD, PhD

https://www.coltonconsortium.org/directory/christopher-pittenger-md-phd/

Elizabeth Mears and House Jameson Professor, Department of Psychiatry, Yale School of Medicine, Yale University Dr. Christopher Pittenger is the Mears & Jameson Professor and Deputy Chair for Translational Research […]

Joseph Craft, MD

https://www.coltonconsortium.org/directory/joseph-craft-md/

Paul B. Beeson Professor of Medicine (Rheumatology), Department of Internal Medicine (Rheumatology, Allergy & Immunology), Yale School of Medicine, Yale University Professor of Immunobiology, Department of Immunobiology, Yale School of […]

The Epidermis as a Novel Therapeutic Target in Pemphigus Vulgaris

https://www.coltonconsortium.org/projects/the-epidermis-as-a-novel-therapeutic-target-in-pemphigus-vulgaris/

By profiling genetic and molecular drivers of pemphigus vulgaris across patient skin and blood, this project uncovers genotype-driven inflammatory loops and actionable targets for personalized therapy.

The Role of Glycosylation in Inflammatory Bowel Disease

https://www.coltonconsortium.org/projects/the-role-of-glycosylation-in-inflammatory-bowel-disease/

Investigating how foreign sugar modifications on anti-TNF biologics trigger immune responses in pediatric IBD patients, this project aims to personalize biologic therapy selection and inform safer drug design.

Inhibiting NETosis with Nuclear-Penetrating Antibodies

https://www.coltonconsortium.org/projects/inhibiting-netosis-with-nuclear-penetrating-antibodies/

Repurposing nuclear-penetrating autoantibodies from lupus and scleroderma patients as potent, safe inhibitors of pathogenic NETosis.